A possible link between sensation-seeking status and positive subjective effects of oxycodone in healthy volunteers

Abstract

Sensation seeking is a personality trait that is linked to use and abuse of drugs. Laboratory studies have established that high sensation seekers, as measured by different instruments, are more likely to report abuse liability-related subjective effects from drugs such as nicotine, alcohol, and d-amphetamine than low sensation seekers. One class of drugs that has not been studied to date in this fashion is opioids. Accordingly, a retrospective analysis encompassing five studies that examined oxycodone effects, including its abuse liability-related effects, was conducted in subjects categorized as high or low sensation seekers. In addition, because there appear to be sex differences in how males and females respond to opioids, this factor was taken into account in the analysis. Seventy one subjects who scored on the lower end (15 and 19 low sensation seeking males and females, respectively) or the higher end (23 and 14 high sensation seeking males and females) of the Disinhibition subscale of the Sensation Seeking Scale-Form V were studied for their responses to 0, 10, and 20 mg of oral oxycodone. Ratings of “pleasant bodily sensations” were significantly higher after oxycodone administration than placebo only in male and female high sensation seekers. Ratings of “take again,” “drug liking,” “carefree,” and “elated (very happy)” also tended to differentiate high from low sensation seekers although Group × Dose interactions were only marginally significant with the latter three ratings. Male and female low sensation seekers and female high sensation seekers reported dysphoric effects (e.g., ratings of nauseated) particularly after administration of the 20-mg oxycodone dose. The results of this analysis provide suggestive evidence that high sensation seekers are more likely to experience greater positive subjective effects from oxycodone than low sensation seekers, but likelihood of experiencing negative effects is more complex (involving both sensation seeking status and sex).

Do Resting Plasma β-Endorphin Levels Predict Responses to Opioid Analgesics?

“…Then, participants engaged in the thermal pain task to assess heat pain threshold and tolerance, with the VAS Intensity and VAS Unpleasantness measures again immediately completed to describe the pain experienced during the heat pain tolerance trials. Following the final pain task, participants completed the Opioid Adjective Rating Scale 45 to describe extent of drug-related side effects being experienced, using a 0 (“Not at All”) to 4 (“Extremely”) Scale. All participants remained in the lab under observation for 2 hours after peak drug activity had been achieved to allow drug effects to remit, after which they were released to a responsible adult.…”

Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness

“…37 This questionnaire consists of 26 items that reflect known opioid side effects and each item is rated on a 100mm VAS scale (anchored with “not at all” and “extremely”). 24 As we have done previously, 17 we conducted a principal components analysis (PCA) to reduce the number of variables examined and substantially reduce the number of analyses performed.…”

The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients

“…Non-analgesic subjective effects of morphine were assessed at the end of the acute pain protocol (see below) using the DELTA questionnaire and VAS opioid effects measures taken from Zacny 47,49 . The DELTA questionnaire asks participants to rate the magnitude of overall drug effects ( D rug E ffects; 0-5 scale), the degree of drug liking (Drug L iking; 0-100, with 50 indicating a neutral response), and the level of desire to take the drug again ( T ake A gain; 0-100, with 50 indicating a neutral response).…”